Spirulina Complex Polysaccharides Suppress the Growth of Glioma in T Lymphocyte- and Macrophage-dependent Manner by Akira, Tominaga et al.
101
Spirulina Complex Polysaccharides Suppress the Growth of 
Glioma in T Lymphocyte- and Macrophage-dependent Manner
Akira Tominaga1*, Yu Kawanishi2, Takahiro Taguchi1, Toshio Yawata2, 
Hiromi Okuyama3, Yutaka Kusumoto3, Shiro Ono3, Keiji Shimizu2
1 Laboratory of Human Health and Medical Science, Graduate School of Kuroshio Science, and
  Department of Molecular and Cellular Biology, Kochi Medical School, Kochi University,
2 Department of Neurosurgery, Kochi Medical School, Kochi University.
3 Laboratory of Immunology, Faculty of Pharmacy, Osaka Ohtani University,
1,2 Kohasu, Okoh-cho, Nankoku, Kochi 783-8505 Japan, 
3 3-11-1, Nishikiorikita, Tondabayashi, Osaka 584-8540, Japan,
ABSTRACT 
Murine RSV-M glioma cells have a feature of endothelial cells. Indeed, they express an endothelial 
cell marker CD31 in vitro. However, CD31 expression was not observed in RSV-M cells growing in 
vivo. We have reported that down-regulating angiogenesis with Spirulina complex polysaccharides 
(CPS) suppressed glioma growth via a Toll-like receptor (TLR) 4 signal. RSV-M cells were implanted 
subcutaneously (S.C.) in C3H/HeN mice and into TLR4 mutant C3H/HeJ mice. Treatment with either 
Spirulina CPS or Escherichia coli (E. coli) lipopolysaccharides (LPS) strongly suppressed RSV-M 
glioma cell growth in C3H/HeN but not C3H/HeJ mice. Both Spirulina CPS and E. coli LPS induced 
NFκB activation and their responses were suppressed by pre-incubating these polysaccharides with 
polymyxin B, suggesting that the chemical nature is shared between these two complex polysac-
charides. Administration of anti-CD8 antibodies, anti-CD4 plus anti-CD8 antibodies or anti-asialo 
GM1 antibodies enhanced glioma growth, suggesting that T cells, and natural killer (NK) cells or 
macrophages were involved in the suppression of the tumor growth by Spirulina CPS. In this review, 
we focused on examining whether macrophages or NK cells are responsible for the suppression of 
the glioma growth. We found that both Spirulina CPS and E. coli LPS suppressed tumor growth by 
activating F4/80 positive macrophages. In conclusion, Spirulina CPS suppressed the tumor growth 
by activating both T cells and macrophages and down-regulating angiogenesis. On the other hand, E. 
coli LPS suppressed glioma growth by activating macrophages or NK cells but not T cells, without 
changing the level of angiogenesis.
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1. Introduction
We have explored the toll-like receptor (TLR) 
responsive materials from algae such as cyanobacte-
rium, blue-green alga. We found that Spirulina CPS are 
effective in inducing NFκB activation in response to 
either TLR2 or TLR4 (Tominaga et al., 2010). Spirulina 
(Arthrospira platensis) is a Gram-negative, oxygenic, 
photosynthetic, and filamentous cyanobacterium that 
both the Aztecs living near Lake Texcoco in Mexico and 
the Kanembu tribe, residing near Lake Chad in Africa, 
consumed as a food. It is reported that the Kanembu 
tribe made dried biscuits called “dihe” from Spirulina 
collected from the waters of the alkaline lakes in the 
Kanem area, northeast of Lake Chad and ingested them 
historically as part of a daily protein diet (Belay et al., 
2008). We used Spirulina pacifica that was selected 
from a strain of edible Arthrospira platensis in 1984 by 
Cyanotech (a generous gift from Dr. Gerald Cysewski, 
Cyabotech, Kailua-Kona, Hawaii). Westphal fractions 
(hot phenol extracts) of Spirulina were prepared as 
described by Westphal et al., 1965, and Kawanishi, et 
al., 2013 (a generous gift from Dr. Satoshi Fukuoka).
We have compared TLR2 or TLR4 responsive 
materials among algae extracts using Golenbock’s 
Chinese hamster ovary derived fibroblast like cells (CHO 
cells) engineered to express human CD25 in response to 
NFκB induced by the TLR2- or TLR4-binding molecules 
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(Delude et al., 1998, Medvedev et al., 2001). Alginic 
acid prepared from Macrocystis pyrifera (Kelp) stimu-
lated TLR4 but not TLR2 to activate NFκB. Fucoidan 
from Fucus vesiculosus activated NFκB efficiently via 
TLR4 but weakly via TLR2 signaling. Polysaccharides 
from Petalonia binghamiae activated NFκB weakly in 
TLR2- and TLR4-dependent manner. Westphal fraction 
of Escherichia coli, lipopolysaccharides (LPS) stimu-
lated TLR4 much more efficiently to activate NFκB 
compared to TLR2. In contrast, the Westphal fraction of 
Spirulina pacifica (Spirulina complex polysaccharides: 
Spirulina CPS) activated NFκB weakly via either the 
TLR2 or TLR4 pathway (Tominaga et al., 2010).  
Although E. coli LPS suppressed the growth of 
gliomas inoculated subcutaneously in a TLR4-dependent 
manner, it is well known that E. coli LPS are highly 
toxic (Chicoine et al., 2007). Therefore, we compared 
the anti-tumor activity of Spirulina CPS with that of E. 
coli LPS against gliomas (Kawanishi et al., 2013) and 
found that both Spirulina CPS and E. coli LPS strongly 
suppressed RSV-M glioma cell growth in C3H/HeN, but 
not C3H/HeJ, mice. By the re-challenge experiments, we 
noticed that Spirulina CPS but not E. coli LPS enhance 
the ability to generate acquired immunity. We proved 
that the anti-glioma activity of Spirulina CPS depends 
on CD8+ and CD4+ T cells through depletion experiments 
using anti-CD4 or anti-CD8 antibodies (Kawanishi et 
al., 2013). We also showed suggestive evidence that 
Spirulina CPS have a unique feature in that they sup-
press angiogenesis, in part by regulating the serum level 
of IL-17 (Kawanishi et al., 2013).
In this review, we focused on macrophages that 
are activated in gliomas when Spirulina CPS are admin-
istered. We found that Spirulina CPS activated both T 
cells and macrophages in gliomas, an effect which is 
negatively correlated with the level of angiogenesis in 
gliomas.  We also discuss the nature of gliomas in terms 
of expression of CD31. 
2.  Similarity of chemical natures between E. coli 
LPS and Spirulina CPS 
Although E. coli LPS induced a higher level of 
NFκB than Spirulina CPS as measured in the expres-
sion intensity of human CD25 in Chinese hamster ovary 
cells 3E10 (TLR2- and TLR4+) (Tominaga et al., 2010), 
Spirulina CPS induced a weak but significant level of 
NFκB at a concentration of one microgram/ml (Fig. 1). 
We pre-incubated both E. coli LPS and Spirulina CPS 
with polymyxin B to see the effects of this antibiotic 
on the abilities of these polysaccharides to induce the 
expression of NFκB in 3E10 cells. As shown in Fig. 1, 
Fig. 1. Polymyxin B suppresses NFκB-inducing ability of E. coli LPS and Spirulina CPS.
NFκB generating ability of each polysaccharide fraction was detected by measuring the expression level of human CD25 in 3E10 
Chinese hamster ovary cells established by Golenbock. Human CD25 was detected by phycoerythrin-coupled anti-human CD25 
antibodies and the fluorescence intensity was detected by a flowcytometer. The background is shown as the left-hand peak expressed 
with a thinner line in each panel that is stained with phycoerythrin-coupled control IgG. Levels of human CD25 induced by both 
polysaccharides were expressed in bold lines. In right panels, both E. coli LPS and Spirulina CPS (100 μg/ml) were pre-incubated 
with polymyxin B (500 μg/ml) at room temperature for 60 minutes before stimulating 3E10 cells. Polymyxin B abolished the expres-
sion of human CD25 on 3E10 cells induced by either E. coli LPS or Spirulina CPS.
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polymyxin B could abolish the NFκB inducing activity 
of both polysaccharides, suggesting that they share the 
same chemical nature. It is highly possible that Spirulina 
CPS have a moiety that resembles lipid A, since poly-
myxin B reportedly binds to the lipid A portion of bacte-
rial LPS (Morrison et al., 1976). 
3.  Anti-tumor activities of Spirulina CPS against 
murine RSV-M glioma depend on the TLR4 
pathway
In order to examine whether anti-tumor activity 
of Spirulina CPS depends on TLR4, we administered 
Spirulina CPS intraperitoneally to RSV-M glioma-
bearing C3H/HeN and TLR4-mutant C3H/HeJ mice 
weekly starting six days after inoculating glioma tumor 
cells subcutaneously on the back of these mice. Both 
Spirulina CPS and E. coli LPS significantly suppressed 
the growth of the glioma in C3H/HeN but not C3H/HeJ 
mice (Fig. 2). This data clearly suggests that Spirulina 
CPS suppress the growth of RSV-M glioma by stimu-
lating the pathway through TLR4 as E. coli LPS does. 
We will describe the difference between E. coli LPS and 
Spirulina CPS in terms of the regulation of immunity 
against RSV-M glioma cells through activities such as 
cytokine production and the use of effector cells against 
glioma cells.
4.  IL-17 is induced by the inoculation of glioma 
cells, and Spirulina CPS suppressed the serum 
level of IL-17 of glioma bearing mice
We observed that anti-IFN-γ antibodies did not 
have any effects when administered four days after 
inoculation of RSV-M glioma cells in either C3H/HeJ or 
C3H/HeN mice. In contrast, anti-IL-17 antibodies sig-
nificantly suppressed the growth of glioma in both strains 
of mice (Kawanishi et al., 2013). Furthermore, we did 
not observe any additive effect in terms of suppression of 
RSV-M glioma cells between anti-IL-17 antibodies and 
Spirulina CPS in C3H/HeN mice. This result suggests 
that Spirulina CPS may suppress the growth of RSV-M 
glioma cells by down-regulating the production of IL-17. 
We measured the level of IL-17 in the serum of 
tumor bearing mice 13 days after tumor inoculation (Fig. 
3). Inoculation of RSV-M glioma cells increased the 
serum level of IL-17 in both C3H/HeJ and C3H/HeN 
mice. E. coli LPS increased the serum level of IL-17 in 
glioma-bearing C3H/HeN but not C3H/HeJ mice. In con-
trast, Spirulina CPS decreased the serum level of IL-17 
in glioma-bearing C3H/HeN but not C3H/HeJ mice. 
Numasaki et al. reported that IL-17 promotes angiogen-
esis not only via stimulation of vascular endothelial cell 
migration but also via elaboration of proangiogenic fac-
tors, which creates an imbalance between angiogenesis 
activators and inhibitors in the vasculature (Numasaki et 
al., 2003). We reported that there were fewer endothelial 
cells expressing CD31 in RSV-M gliomas from Spirulina 
CPS-treated mice than in those from control mice or E. 
coli LPS-treated mice (Kawanishi et al., 2013).
5.  T lymphocytes and macrophages are respon-
sible for the suppression of growth of RSV-M 
glioma by Spirulina complex polysaccharides
To identify the effector cells that suppress the 
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Fig. 2. Effects of E. coli LPS and Spirulina CPS on RSV-M 
glioma cell growth in C3H/HeJ and C3H/HeN.
Five million RSV-M glioma cells were inoculated subcutane-
ously on the backs of C3H/HeN or C3H/HeJ mice. Spirulina 
CPS (20 μg), E. coli LPS (20 μg), or saline were injected intra-
peritoneally every week starting six days after tumor inocula-
tion. Tumor volume was calculated using the formula, volume 
= width2 x length/2 and the data were represented as average 
± standard error (SEM) of 6 female 10-week-old mice per 
group. There are significant differences between the following 
groups (P < 0.01; Student’s t-test): Saline-treated group versus 
Spirulina CPS-treated group and Saline-treated group versus 
E. coli LPS-treated group on days 12, 14, and 19 after tumor 
transplantation in C3H/HeN mice. From Kawanishi et al., 
2013.
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growth of RSV-M glioma cells when Spirulina CPS are 
administered, we depleted the subpopulation of cells 
that may be engaged in this regulation by administering 
antibodies against the surface marker of each subpopula-
tion. As we reported, we found that anti-CD8 antibodies 
enhanced glioma growth when glioma-bearing mice were 
treated with Spirulina CPS, suggesting that CD8+ T cells 
are involved in suppression of tumor growth by Spirulina 
CPS. Although anti-CD4 antibodies alone had no effect 
on tumor growth, they enhanced the glioma growth when 
administered together with anti-CD8 antibodies. These 
results suggest that CD4+ T cells are also involved in 
tumor immunity induced by Spirulina CPS against this 
glioma. Anti-asialo GM1 antibodies enhanced tumor 
growth as efficiently as anti-CD4 and anti-CD8 anti-
bodies, suggesting that NK cells or macrophages are 
involved in the suppression of the growth of RSV-M 
glioma cells by Spirulina CPS.
We tried to identify the asialo GM1-positive effector 
cells that are engaged in the suppression of the growth of 
RSV-M glioma cells. We observed no difference in the 
number of NK cells stained with anti-CD49b antibodies 
(clone DX5) between Spirulina CPS-treated and control 
glioma-bearing mice (data not shown). By staining F4/80 
antigens in the section of gliomas growing in C3H/
HeN mice, we found that the number of F4/80 positive 
macrophages migrated into the glioma by the treatment 
with Spirulina CPS are decreased after the treatment 
with either anti-CD8 antibodies, anti-CD4 antibodies 
plus anti-CD8 antibodies, or anti-asialo GM1 antibodies. 
Spirulina CPS induced more F4/80 macrophage migra-
tion into the tumor mass than E. coli LPS (Fig. 5A, B).
Then, we examined the CD31 expression in glioma 
cells in the same groups in which F4/80 positive cells 
were detected. Although both E. coli LPS and Spirulina 
CPS promoted the migration of F4/80 macrophages 
Fig. 3. Serum concentrations of IL-17 in glioma RSV-M 
bearing mice treated with Spirulina CPS. 
On day 13 after tumor inoculation in the experiment of Fig. 2, 
serum from individual mouse was prepared and IL-17 levels 
were measured using an ELISA as described (Kawanishi et al., 
2013). Spi CPS: Spirulina pacifica complex polysaccharides. 
Results are shown as mean values of 6 mice (pg/ml ± SEM). *: 
P < 0.01, between groups paired with lines (Student’s t-test). 
Modified from reference by Kawanishi et al., 2013.
Fig. 4. Both T cells and asialo GM1 positive cells are 
involved in glioma-suppressing activity of Spirulina CPS. 
Five million RSV-M glioma cells were inoculated subcutane-
ously on the back of C3H/HeN mice. Spirulina CPS (100 μg) 
or saline was injected intraperitoneally every week starting 
six days after tumor inoculation. Data represent means ± SEM 
of 5 female 10-week-old mice per group. Antibodies were 
administered as described (Kawanishi et al., 2013). In brief, 
antibodies were administered at a dose of 100 μg/100 μl/mouse 
on days -1, 0, and +3 before and after tumor transplantation. 
(A) Effects of anti-CD4 and anti-CD8 antibodies on the sup-
pressive effect of Spirulina CPS (Spi CPS) on the growth of 
glioma cells in C3H/HeN mice. There is a significant difference 
between the following groups at the indicated periods (P<0.05; 
student’s t-test): Saline versus Spi CPS; Spi CPS + anti-CD8 
antibodies versus Spi CPS + rat IgG from days 13 to 21; Spi 
CPS + anti-CD8 antibodies versus Spi CPS + anti-CD4 + anti-
CD8 antibodies from days 13 to 18. (B) Effect of anti-asialo 
GM1 antibodies on the suppressive effect of Spirulina CPS on 
the growth of glioma cells in C3H/HeN mice. There is a signifi-
cant difference between the following groups at the indicated 
periods (P<0.05; student’s t-test): Spi CPS + anti-asialo GM1 
antibodies versus Spi CPS + rabbit IgG from days 11 to 21. 
From Kawanishi et al., 2013.
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Fig. 5. Macrophages are involved in the glioma-suppressing activity of Spirulina CPS.
(A) Frozen sections of gliomas prepared from tumor-bearing C3H/HeN mice in Fig. 4 were stained with anti-F4/80 antibodies (2.5 
μg/ml, rat IgG2A, κ, clone: BM8, Bio Legend, San Diego CA) as described (Kawanishi et al., 2013). Representative photomicro-
graphs are shown from experiments conducted in tumor samples from each group of mice. Bar, 50 μm. (B) F4/80 positive cells 
were compared among groups treated with anti-CD4 antibodies, anti-CD8 antibodies, anti-CD4 and anti-CD8 antibodies, and anti-
asialo GM1 antibodies. F4/80 positive cells were counted in a field of 300 μm X 400 μm. Each group consisted of 10 fields randomly 
chosen from tumor sections of each treatment and cell numbers stained with anti-F4/80 antibodies are shown as mean values ± SEM. 
Asterisks indicate significant differences between the groups (P <0.01; ANOVA, Tukey-Kramer’s post hoc test). (C) Frozen sections 
of gliomas prepared from tumor-bearing C3H/HeN mice in (A) were stained with anti-CD31 antibodies as described (Kawanishi et 
al., 2013). CD31 positive cells were compared among groups treated with anti-CD4 antibodies, anti-CD8 antibodies, anti-CD4 and 
anti-CD8 antibodies, and anti-asialo GM1 antibodies. CD31 positive cells were counted in a field of 300 μm X 400 μm. Each group 
consisted of 10 fields randomly chosen from tumor sections of each treatment and cell numbers stained with anti-CD31 antibodies 
are shown as mean values ± SEM. Asterisks indicate significant differences between the groups (P <0.01; ANOVA, Tukey-Kramer’s 
post hoc test). (C) is modified from Kawanishi et al., 2013.
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into the glioma mass, only Spirulina CPS decreased the 
number of CD31-expressing cells. E. coli LPS had no 
effect on the number of CD31-expressing cells in the 
tumor mass (Fig. 5C). Since CD31 is a marker of endo-
thelial cells, this result suggests that Spirulina CPS but 
not E. coli LPS suppressed the angiogenesis in the tumor 
of these RSV-M glioma cells. Interestingly, numbers of 
CD31+ cells in glioma from each Spirulina CPS-treated 
mouse negatively correlated with the F4/80 positive mac-
rophages in the glioma mass (Fig. 5, Fig. 6). The admin-
istration of anti-CD8 antibodies, anti-CD4 antibodies 
plus anti-CD8 antibodies, or anti-asialo GM1 antibodies 
in Spirulina CPS-treated mice decreased F4/80 positive 
macrophages and increased the CD31 positive endothe-
lial cells in the glioma mass. In other words, the level of 
immune responses against RSV-M glioma cells are nega-
tively correlated closely with the level of angiogenesis 
in gliomas of Spirulina CPS-treated mice. It is also sug-
gested that T lymphocytes induced by Spirulina CPS are 
involved in the suppression of angiogenesis.
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6.  RSV-M glioma cells express a higher level of 
CD31 in vitro compared with that in vivo 
Ricci-Vitiani et al. reported that a variable number 
(range 20-90%, mean 60.7%) of endothelial cells in 
glioblastoma carry the same genomic alteration as tumor 
cells, indicating that a significant portion of the vascular 
endothelium has a neoplastic origin (Ricci-Vitiani et 
al., 2010). Wang et al. reported that a subpopulation of 
endothelial cells within glioblastomas harbor the same 
somatic mutations identified within tumor cells, such as 
amplification of EGFR and chromosome 7. They also 
demonstrated the stem-cell-like CD133+ fraction includes 
a subset of vascular endothelial-cadherin (CD144)-
expressing cells that show characteristics of endothelial 
progenitors capable of maturation into endothelial cells. 
They further showed that a subpopulation of the CD133+ 
stem-like cell fraction is multipotent and capable of dif-
ferentiation along tumor and endothelial lineages, pos-
sibly via an intermediate CD133+/CD144+ progenitor cell 
(Wang et al., 2010). 
The process of neurogenesis in the adult brain has 
been primarily confined to the forebrain subventricular 
zone and subgranular zone of the dentate gyrus (Chesler 
et al., 2013). Within the subventricular zone of the mam-
malian brain, clusters of capillaries, associated growth 
factors such as brain-derived neurotrophic factor (BDNF), 
vascular endothelial growth factor (VEGF), and extra-
cellular matrix components such as tenascin-C and 
chondroitin sulfate, create an environment which fosters 
stem cell growth and regulates proliferation and cell fate 
through cross talk and maintenance of local environ-
mental factors such as pH and oxygen tension. Gliomas 
are typically highly vascularized tumors often with 
Fig. 6. Staining of RSV-M glioma cells with anti-CD31 antibodies in vitro.
In vitro RSV-M glioma cells were grown in Dulbecco’s-modified Eagle medium with high glucose supplemented with 8% fetal calf 
serum, 20 U/ml penicillin, 50 μg/ml kanamycin. RSV-M glioma cells were stained with anti-CD31 antibodies (Rat IgG2a, κ, 390, 
BioLegend, San Siego, CA) using Simple stain mouse MAX-PO (F(ab)’2 goat anti-Rat Ig and peroxidase coupled to the amino acid 
polymer) and 3,3’-diaminobenzidine according to the manufacture’s protocol (Nichirei-Biosciences Inc., Tokyo, Japan) as described 
(Kawanishi et al., 2013). Samples were counterstained with hematoxylin.
F4/80 Rat-IgG
CD31
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extensive capillary beds that can provide a similar vas-
cular niche for glioma initiating cells to reside in (Chesler 
et al., 2013). Calabrese et al. found that CD133+/Nestin+ 
glioma-derived stem cells were closely associated with 
capillary associated endothelial cells (Calabrese et al., 
2007). Golebiewska et al. reported that CD133-positive 
cells often associated with cancer stem cells in glio-
blastoma biopsies, do not represent a homogeneous cell 
population and include CD31-positive endothelial cells 
(Golebiewska et al., 2013).  
We found that almost all RSV-M glioma cells 
express a high level of CD31 in vitro and this high level 
of expression of CD31 was not observed in vivo tumor 
(Fig. 6, Kawanishi et al., 2013). Once RSV-M glioma 
cells were inoculated subcutaneously on the back of 
mice, they decreased the expression level of CD31 and 
gradually formed the blood vessels to support their own 
growth.
We have hypothesized that the way Spirulina CPS 
inhibit angiogenesis is by down-regulating the production 
of IL-17. It is reported that TGF-β has been expressed 
in the normal subventricular zone, having a role in 
progenitor differentiation (Schneider et al., 1992). It is 
also found that glioblastoma or macrophages in glioma 
expressed TGF-β (Schneider et al., 1992). We have 
evidence that Spirulina CPS suppress the production of 
TGF-β and IL-6 by macrophages (unpublished obser-
vation). This result suggests that Spirulina CPS down-
regulate the production of IL-17 by suppressing the 
production of TGF-β, IL-6, or IL-23 from macrophages. 
As described in Fig. 7, in the environment surrounding 
glioma cells, macrophages or other immune competent 
cells, or glioma cells by themselves secrete TGF-β, IL-6, 
or IL-23 that induce IL-17 producing cells, resulting in 
the high level of angiogenesis. Although Spirulina CPS 
reduce the level of IL-17 in the microenvironment sur-
rounding glioma cells, E. coli LPS induce the produc-
tion of TGF-β, IL-6, or IL-23 (unpublished observation) 
resulting in the high level of IL-17.
In conclusion, Spirulina CPS suppress the growth of 
glioma in a TLR4 dependent way by reducing the angio-
genesis via down-regulation of the production of IL-17. 
Invasion of macrophages, CD4+ T cells, and CD8+ T cells 
are important for this suppression of angiogenesis. Since 
glioma cells are derived from stem cells that have char-
acteristics of endothelial cells in the presence of TGF-β, 
Spirulina CPS may be an efficient reagent to suppress 
the growth of this tumor. As shown in Fig. 7, TGF-β also 
induces Treg cells that suppress the immunity against 
tumor cells. Spirulina CPS may also be useful to inhibit 
the suppression of antitumor immunity by Treg cells, 
because they have the ability to down-regulate the pro-
duction of TGF-β.
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